PARP inhibitors and stratified treatment of prostate cancer

Expert Rev Anticancer Ther. 2016 Dec;16(12):1213-1215. doi: 10.1080/14737140.2016.1243474. Epub 2016 Oct 17.
No abstract available

Keywords: BRCA1/2 mutation; Biomarker; PARP inhibitor; prostate cancer; stratification; targeted therapy.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Humans
  • Male
  • Neoplasm Metastasis
  • Poly(ADP-ribose) Polymerase Inhibitors / pharmacology*
  • Poly(ADP-ribose) Polymerases / drug effects
  • Poly(ADP-ribose) Polymerases / metabolism
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Survival Rate

Substances

  • Antineoplastic Agents
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Poly(ADP-ribose) Polymerases